Dr Reddys Laboratories (RDY) Other Non Operating Income (2009 - 2018)
Dr Reddys Laboratories (RDY) posted quarterly Other Non Operating Income of -$9.0 million for Q2 2018, down 125.0% quarter-over-quarter from -$4.0 million in Q1 2018.
Dr Reddys Laboratories (RDY) Other Non Operating Income (2009 - 2018) Analysis & Trends
Dr Reddys Laboratories' Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$9.0 million for Q2 2018.
- In Q2 2018, Other Non Operating Income changed N/A year-over-year to -$9.0 million; the TTM figure through Jun 2018 stood at -$21.0 million (changed N/A YoY), while the FY2018 annual figure was -$4.0 million, changed N/A from the prior year.
- Other Non Operating Income for Q2 2018 stood at -$9.0 million, down from -$4.0 million in the prior quarter.
- The five-year high for Other Non Operating Income was -$4.0 million in Q1 2018, with the low at -$9.0 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -9.00 Mn |
| Mar 31, 2018 | -4.00 Mn |
| Mar 31, 2014 | -6.00 Mn |
| Sep 30, 2009 | -2.00 Mn |
| Jun 30, 2009 | -1.00 Mn |